title: [Telaprevir-benefit assessment of the Institute for Quality and Efficiency in Health Care (IQWiG) in accordance with § 35a SGB V (dosing evaluation)].
mesh_terms: D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D005762:Gastroenterology / Q000592:standards*; D005858:Germany; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D009842:Oligopeptides; C486464:telaprevir